Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-30

FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approves Upsher-Smith's generic diltiazem hydrochloride through an original ANDA (ANDA205231) for use as a calcium channel blocker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diltiazem hydrochloride (Diltiazem hydrochloride)

Snippet

ORIG AP for DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)